The company
MannKind Corporation
MNKD · Nasdaq
MNKD stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 11.3% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 34
- Industry in uptrend
- 32% -7 in 4 wk
- Insider buys, 12 months
- $518K
- Insider sales, 12 months
- $4.3M
- Officials’ trades on record
- 0
- Institutions holding
- 243 (+7)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Steven B. BinderDirector | sold | 39,051at $3.29 | 25 Sep 2026filed 28 Sep 2026 |
| Steven B. BinderDirector | sold | 33,558at $3.81 | 10 Sep 2026filed 14 Sep 2026 |
| Steven B. BinderDirector | sold | 39,051at $4.06 | 7 Aug 2026filed 10 Aug 2026 |
| Steven B. BinderDirector | sold | 52,485at $4.06 | 17 Jul 2026filed 17 Jul 2026 |
| David ThomsonEVP Genl Counsel & Secretary | sold | 24,109at $4.05 | 17 Jul 2026filed 17 Jul 2026 |
| David ThomsonEVP Genl Counsel & Secretary | sold | 3,033at $3.29 | 12 May 2026filed 13 May 2026 |
| Steven B. BinderDirector | sold | 16,940at $3.29 | 12 May 2026filed 13 May 2026 |
| Michael CastagnaChief Executive Officer | bought | 100,000at $2.59 | 10 Mar 2026filed 10 Mar 2026 |
| Stuart A. TrossChief People & Workpl Officer | sold | 47,006at $6.33 | 8 Jan 2026filed 9 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 32,133,223$136.9M | +3,532,225+12.4% |
| Rubric Capital Management LPadded · filed 14 Aug 2026 | 18,000,000$76.7M | +14,379,587+397.2% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 16,174,043$68.9M | -2,509,440−13.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 13,169,392$56.1M | +278,326+2.2% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 7,947,203$33.9M | +442,056+5.9% |
| WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026 | 7,844,807$33.4M | +4,561,628+138.9% |
| Frazier Life Sciences Management, L.P.added · filed 14 Aug 2026 | 6,600,000$28.1M | +700,000+11.9% |
| Deep Track Capital, LPnew · filed 14 Aug 2026 | 6,000,000$25.6M | +6,000,000 |
| 180 WEALTH ADVISORS, LLCadded · filed 7 Jul 2026 | 4,959,351$21.1M | +667,648+15.6% |
| FMR LLCadded · filed 13 Aug 2026 | 4,101,046$17.5M | +620,082+17.8% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.